Minimum Residual Disease in Acute Lymphoblastic Leukemia
5 Views
administrator
08/04/23
In this segment, Jeffrey Lancet, MD; Raoul Tibes, MD; and Mark R. Litzow, MD, describe various methodologies in monitoring minimum residual disease in acute lymphoblastic leukemia.
-
Category
Show more
Facebook Comments
No comments found